3.26.1 html 206 300 1 true 81 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.vaxart.com/20260331/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.vaxart.com/20260331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.vaxart.com/20260331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) Sheet http://www.vaxart.com/20260331/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-income-loss-unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.vaxart.com/20260331/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.vaxart.com/20260331/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Organization and Nature of Business Sheet http://www.vaxart.com/20260331/role/statement-note-1-organization-and-nature-of-business Note 1 - Organization and Nature of Business Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.vaxart.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Fair Value of Financial Instruments Sheet http://www.vaxart.com/20260331/role/statement-note-3-fair-value-of-financial-instruments Note 3 - Fair Value of Financial Instruments Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Balance Sheet Components Sheet http://www.vaxart.com/20260331/role/statement-note-4-balance-sheet-components Note 4 - Balance Sheet Components Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Revenue Sheet http://www.vaxart.com/20260331/role/statement-note-5-revenue Note 5 - Revenue Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Liabilities Related to Sale of Future Royalties Sheet http://www.vaxart.com/20260331/role/statement-note-6-liabilities-related-to-sale-of-future-royalties Note 6 - Liabilities Related to Sale of Future Royalties Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Leases Sheet http://www.vaxart.com/20260331/role/statement-note-7-leases Note 7 - Leases Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Commitments and Contingencies Sheet http://www.vaxart.com/20260331/role/statement-note-8-commitments-and-contingencies Note 8 - Commitments and Contingencies Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Stockholders' Equity Sheet http://www.vaxart.com/20260331/role/statement-note-9-stockholders-equity Note 9 - Stockholders' Equity Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Equity Incentive Plans Sheet http://www.vaxart.com/20260331/role/statement-note-10-equity-incentive-plans Note 10 - Equity Incentive Plans Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders Sheet http://www.vaxart.com/20260331/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Segment Reporting Sheet http://www.vaxart.com/20260331/role/statement-note-12-segment-reporting Note 12 - Segment Reporting Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Subsequent Events Sheet http://www.vaxart.com/20260331/role/statement-note-13-subsequent-events- Note 13 - Subsequent Events Notes 19 false false R20.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 20 false false R21.htm 995465 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.vaxart.com/20260331/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.vaxart.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies 21 false false R22.htm 995466 - Disclosure - Note 3 - Fair Value of Financial Instruments (Tables) Sheet http://www.vaxart.com/20260331/role/statement-note-3-fair-value-of-financial-instruments-tables Note 3 - Fair Value of Financial Instruments (Tables) Tables http://www.vaxart.com/20260331/role/statement-note-3-fair-value-of-financial-instruments 22 false false R23.htm 995467 - Disclosure - Note 4 - Balance Sheet Components (Tables) Sheet http://www.vaxart.com/20260331/role/statement-note-4-balance-sheet-components-tables Note 4 - Balance Sheet Components (Tables) Tables http://www.vaxart.com/20260331/role/statement-note-4-balance-sheet-components 23 false false R24.htm 995468 - Disclosure - Note 6 - Liabilities Related to Sale of Future Royalties (Tables) Sheet http://www.vaxart.com/20260331/role/statement-note-6-liabilities-related-to-sale-of-future-royalties-tables Note 6 - Liabilities Related to Sale of Future Royalties (Tables) Tables http://www.vaxart.com/20260331/role/statement-note-6-liabilities-related-to-sale-of-future-royalties 24 false false R25.htm 995469 - Disclosure - Note 7 - Leases (Tables) Sheet http://www.vaxart.com/20260331/role/statement-note-7-leases-tables Note 7 - Leases (Tables) Tables http://www.vaxart.com/20260331/role/statement-note-7-leases 25 false false R26.htm 995470 - Disclosure - Note 9 - Stockholders' Equity (Tables) Sheet http://www.vaxart.com/20260331/role/statement-note-9-stockholders-equity-tables Note 9 - Stockholders' Equity (Tables) Tables http://www.vaxart.com/20260331/role/statement-note-9-stockholders-equity 26 false false R27.htm 995471 - Disclosure - Note 10 - Equity Incentive Plans (Tables) Sheet http://www.vaxart.com/20260331/role/statement-note-10-equity-incentive-plans-tables Note 10 - Equity Incentive Plans (Tables) Tables http://www.vaxart.com/20260331/role/statement-note-10-equity-incentive-plans 27 false false R28.htm 995472 - Disclosure - Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders (Tables) Sheet http://www.vaxart.com/20260331/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-tables Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders (Tables) Tables http://www.vaxart.com/20260331/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders 28 false false R29.htm 995473 - Disclosure - Note 12 - Segment Reporting (Tables) Sheet http://www.vaxart.com/20260331/role/statement-note-12-segment-reporting-tables Note 12 - Segment Reporting (Tables) Tables http://www.vaxart.com/20260331/role/statement-note-12-segment-reporting 29 false false R30.htm 995474 - Disclosure - Note 1 - Organization and Nature of Business (Details Textual) Sheet http://www.vaxart.com/20260331/role/statement-note-1-organization-and-nature-of-business-details-textual Note 1 - Organization and Nature of Business (Details Textual) Details http://www.vaxart.com/20260331/role/statement-note-1-organization-and-nature-of-business 30 false false R31.htm 995475 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.vaxart.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details 31 false false R32.htm 995476 - Disclosure - Note 3 - Fair Value of Financial Instruments (Details Textual) Sheet http://www.vaxart.com/20260331/role/statement-note-3-fair-value-of-financial-instruments-details-textual Note 3 - Fair Value of Financial Instruments (Details Textual) Details http://www.vaxart.com/20260331/role/statement-note-3-fair-value-of-financial-instruments-tables 32 false false R33.htm 995477 - Disclosure - Note 3 - Fair Value of Financial Instruments - Financial Assets Measured on a Recurring Basis (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-3-fair-value-of-financial-instruments-financial-assets-measured-on-a-recurring-basis-details Note 3 - Fair Value of Financial Instruments - Financial Assets Measured on a Recurring Basis (Details) Details 33 false false R34.htm 995478 - Disclosure - Note 4 - Balance Sheet Components (Details Textual) Sheet http://www.vaxart.com/20260331/role/statement-note-4-balance-sheet-components-details-textual Note 4 - Balance Sheet Components (Details Textual) Details http://www.vaxart.com/20260331/role/statement-note-4-balance-sheet-components-tables 34 false false R35.htm 995479 - Disclosure - Note 4 - Balance Sheet Components - Cash and Cash Equivalents and Investments (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-4-balance-sheet-components-cash-and-cash-equivalents-and-investments-details Note 4 - Balance Sheet Components - Cash and Cash Equivalents and Investments (Details) Details 35 false false R36.htm 995480 - Disclosure - Note 4 - Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-4-balance-sheet-components-prepaid-expenses-and-other-current-assets-details Note 4 - Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) Details 36 false false R37.htm 995481 - Disclosure - Note 4 - Balance Sheet Components - Property and Equipment, Net (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-4-balance-sheet-components-property-and-equipment-net-details Note 4 - Balance Sheet Components - Property and Equipment, Net (Details) Details 37 false false R38.htm 995482 - Disclosure - Note 4 - Balance Sheet Components - Intangible Assets (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-4-balance-sheet-components-intangible-assets-details Note 4 - Balance Sheet Components - Intangible Assets (Details) Details 38 false false R39.htm 995483 - Disclosure - Note 4 - Balance Sheet Components - Estimated Future Amortization Expense (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-4-balance-sheet-components-estimated-future-amortization-expense-details Note 4 - Balance Sheet Components - Estimated Future Amortization Expense (Details) Details 39 false false R40.htm 995484 - Disclosure - Note 4 - Balance Sheet Components - Deferred Revenue, by Arrangement, Disclosure (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-4-balance-sheet-components-deferred-revenue-by-arrangement-disclosure-details Note 4 - Balance Sheet Components - Deferred Revenue, by Arrangement, Disclosure (Details) Details 40 false false R41.htm 995485 - Disclosure - Note 4 - Balance Sheet Components - Accrued Liabilities (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-4-balance-sheet-components-accrued-liabilities-details Note 4 - Balance Sheet Components - Accrued Liabilities (Details) Details 41 false false R42.htm 995486 - Disclosure - Note 5 - Revenue (Details Textual) Sheet http://www.vaxart.com/20260331/role/statement-note-5-revenue-details-textual Note 5 - Revenue (Details Textual) Details http://www.vaxart.com/20260331/role/statement-note-5-revenue 42 false false R43.htm 995487 - Disclosure - Note 6 - Liabilities Related to Sale of Future Royalties (Details Textual) Sheet http://www.vaxart.com/20260331/role/statement-note-6-liabilities-related-to-sale-of-future-royalties-details-textual Note 6 - Liabilities Related to Sale of Future Royalties (Details Textual) Details http://www.vaxart.com/20260331/role/statement-note-6-liabilities-related-to-sale-of-future-royalties-tables 43 false false R44.htm 995488 - Disclosure - Note 6 - Liabilities Related to Sale of Future Royalties - Deferred Revenue Activity (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-6-liabilities-related-to-sale-of-future-royalties-deferred-revenue-activity-details Note 6 - Liabilities Related to Sale of Future Royalties - Deferred Revenue Activity (Details) Details 44 false false R45.htm 995489 - Disclosure - Note 7 - Leases (Details Textual) Sheet http://www.vaxart.com/20260331/role/statement-note-7-leases-details-textual Note 7 - Leases (Details Textual) Details http://www.vaxart.com/20260331/role/statement-note-7-leases-tables 45 false false R46.htm 995490 - Disclosure - Note 7 - Leases - Lease Liabilities Payment Obligations (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-7-leases-lease-liabilities-payment-obligations-details Note 7 - Leases - Lease Liabilities Payment Obligations (Details) Details 46 false false R47.htm 995491 - Disclosure - Note 7 - Leases - Operating Lease Expenses (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-7-leases-operating-lease-expenses-details Note 7 - Leases - Operating Lease Expenses (Details) Details 47 false false R48.htm 995492 - Disclosure - Note 8 - Commitments and Contingencies (Details Textual) Sheet http://www.vaxart.com/20260331/role/statement-note-8-commitments-and-contingencies-details-textual Note 8 - Commitments and Contingencies (Details Textual) Details http://www.vaxart.com/20260331/role/statement-note-8-commitments-and-contingencies 48 false false R49.htm 995493 - Disclosure - Note 9 - Stockholders' Equity (Details Textual) Sheet http://www.vaxart.com/20260331/role/statement-note-9-stockholders-equity-details-textual Note 9 - Stockholders' Equity (Details Textual) Details http://www.vaxart.com/20260331/role/statement-note-9-stockholders-equity-tables 49 false false R50.htm 995494 - Disclosure - Note 9 - Stockholders' Equity - Shares of Common Stock Reserved for Issuance (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-9-stockholders-equity-shares-of-common-stock-reserved-for-issuance-details Note 9 - Stockholders' Equity - Shares of Common Stock Reserved for Issuance (Details) Details 50 false false R51.htm 995495 - Disclosure - Note 9 - Stockholders' Equity - Summary of Warrants Outstanding (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-9-stockholders-equity-summary-of-warrants-outstanding-details Note 9 - Stockholders' Equity - Summary of Warrants Outstanding (Details) Details 51 false false R52.htm 995496 - Disclosure - Note 10 - Equity Incentive Plans (Details Textual) Sheet http://www.vaxart.com/20260331/role/statement-note-10-equity-incentive-plans-details-textual Note 10 - Equity Incentive Plans (Details Textual) Details http://www.vaxart.com/20260331/role/statement-note-10-equity-incentive-plans-tables 52 false false R53.htm 995497 - Disclosure - Note 10 - Equity Incentive Plans - Summary of Stock Option Transactions (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-10-equity-incentive-plans-summary-of-stock-option-transactions-details Note 10 - Equity Incentive Plans - Summary of Stock Option Transactions (Details) Details 53 false false R54.htm 995498 - Disclosure - Note 10 - Equity Incentive Plans - Assumptions of Options (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-10-equity-incentive-plans-assumptions-of-options-details Note 10 - Equity Incentive Plans - Assumptions of Options (Details) Details 54 false false R55.htm 995499 - Disclosure - Note 10 - Equity Incentive Plans - Total Stock-based Compensation Recognized for Options (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-10-equity-incentive-plans-total-stockbased-compensation-recognized-for-options-details Note 10 - Equity Incentive Plans - Total Stock-based Compensation Recognized for Options (Details) Details 55 false false R56.htm 995500 - Disclosure - Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders (Details Textual) Sheet http://www.vaxart.com/20260331/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-details-textual Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders (Details Textual) Details http://www.vaxart.com/20260331/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-tables 56 false false R57.htm 995501 - Disclosure - Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders - Calculation of Basic and Diluted Net (Loss) Income Per Share (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-calculation-of-basic-and-diluted-net-loss-income-per-share-details Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders - Calculation of Basic and Diluted Net (Loss) Income Per Share (Details) Details http://www.vaxart.com/20260331/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-tables 57 false false R58.htm 995502 - Disclosure - Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-summary-of-antidilutive-securities-details Note 11 - Net Income (Loss) Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Details) Details http://www.vaxart.com/20260331/role/statement-note-11-net-income-loss-per-share-attributable-to-common-stockholders-tables 58 false false R59.htm 995503 - Disclosure - Note 12 - Segment Reporting (Details Textual) Sheet http://www.vaxart.com/20260331/role/statement-note-12-segment-reporting-details-textual Note 12 - Segment Reporting (Details Textual) Details http://www.vaxart.com/20260331/role/statement-note-12-segment-reporting-tables 59 false false R60.htm 995504 - Disclosure - Note 12 - Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details) Sheet http://www.vaxart.com/20260331/role/statement-note-12-segment-reporting-schedule-of-segment-reporting-information-by-segment-details Note 12 - Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details) Details 60 false false R61.htm 995505 - Disclosure - Note 13 - Subsequent Events (Details Textual) Sheet http://www.vaxart.com/20260331/role/statement-note-13-subsequent-events-details-textual Note 13 - Subsequent Events (Details Textual) Details http://www.vaxart.com/20260331/role/statement-note-13-subsequent-events- 61 false false All Reports Book All Reports vxrt-20260331.xsd vxrt-20260331_cal.xml vxrt-20260331_def.xml vxrt-20260331_lab.xml vxrt-20260331_pre.xml vxrt20260331_10q.htm http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 true true